National sponsor of the Motherisk Program

Further Reading

• Ther Drug Monit 2002;24(1):15.22.
  Loebstein R, Koren G: Clinical relevance of therapeutic drug monitoring during pregnancy.
• Exposure to electromagnetic fields during pregnancy
  Gideon Koren, MD, FRCPC
• Clin Perinatol. 1999 Mar;26(1):75-86, vii. Review.
  Bishai R, Koren G: Maternal and obstetric effects of prenatal drug exposure.
• New England Journal of Medicine 1998 Apr 16;338(16):1128-1137 No abstract available.
  Koren G, Pastuszak A, Ito S: Drugs in pregnancy.
• [Review] [135 refs] Clinical Pharmacokinetics 33(5):328-43, 1997 Nov.
  Loebstein R, Lalkin A, Koren G: Pharmacokinetic changes during pregnancy and their clinical relevance.
• 
  Koren G, Nulman I: Antenatal sonographic finding in fetuses exposed to teratogenic agents. Dev Brain Dysfunction 6: 305-316, 1993.
• Spielberg SP, Koren G: Drugs, chemicals and CNS malformations: Disorders of the developing nervous system. Editors: Drs. H.J. Hoffman and F. Epstein. Blackwell Scientific Publications, 301-312, 1986.
  In Book:
• 
  Koren G, Brill-Edwards M, Miskin M: Antenatal sonography of fetal malformations associated with drugs and chemicals - a guide. Am J Obstet Gynecol 156: 79-85, 1987.
• Med Toxicol 3: 307-323, 1988.
  Bologa-Campeanu M, Koren G, Rieder M, McGuigan M: Prenatal adverse effects of various drugs and chemicals: A review of substances of frequent concern to mothers in the community.
• Clin Toxicol 26: ix-xv, 1988. No abstract available.
  Cribb A, Koren G: Pursuing teratogenic causes of multiple congenital contractures.
• Vet Hum Toxicol, 29: 456--458, 1987. No abstract available.
  Koren G, Bologa-Campeanu M, Pellegrini E, Rieder M, McGuigan M: Information and consultation for drugs, chemicals, and radiation exposure in pregnancy; What bothers women most commonly.
• Can Med Assoc J 147: 988, 1992. No abstract available.
  Koren G, Eliopoulos C: Getting the facts straight.
• 
  Einarson A: Patient Advice on Drug Use In Pregnancy and Lactation, A Motherisk specialist's perspective. Pharmacy Connection Jan/Feb: 17-18, 1995.
• 
  Koren G: Drug therapy in pregnancy: What's right? What's wrong? Journal of The Society of Obsteticians and Gynecologists of Canada 11: 1, 1989.
• 
  Koren G, Pellegrini E: A clinical approach to drug, chemical and radiation exposure in pregnancy. Journal of The Society of Obstetricians and Gynecologists of Canada. 11, 5-12, 1989.
• 
  Koren G: Neonatal Toxicology. Medicine North America Issue 2, pp 121-130, 1989.
• 
  Koren G: Counseling women on reproductive risks of drugs, chemicals and radiation. Medicine North America: 1781-1793, December 1990.
• 16: 63-75, 1992. No abstract available.
  Levy M, Koren G: Clinical toxicology of the neonate Semin Perinatol
• Matsui D, Koren G: Perinatal Toxicology, In: Pediatric Pathophysiology, (Gluckman & Heymann, eds), Edward Arnold, Ltd, London (In Press).
  In Book:
• Bologa M et al: Direct drug toxicity to the fetus. Koren G (ed): Maternal-Fetal Toxicology, 2nd edition, Marcel Dekker, NY, 267-300. 1994.
  In Book:
• a survey of community pharmacists in three countries. Pharm World Sci 23: 76-81, 2001
  Lyszkiewicz DA, Gerichhausen S, Bjornsdottir I, Einarson TR, Koren G, Einarson A: Evidence based information on drug use during pregnancy: